Development and Validation of a Propionate Metabolism-Related Gene Signature for Prognostic Prediction of Hepatocellular Carcinoma

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345–1362.
   PubMed Web of Science ®Google Scholar
• Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76(3):681–693. doi:10.1016/j.jhep.2021.11.018
   PubMed Web of Science ®Google Scholar
• Halarnkar PP, Blomquist GJ. Comparative aspects of propionate metabolism. Comp Biochem Physiol B. 1989;92(2):227–231.
   PubMed Web of Science ®Google Scholar
• Santos LPA, Assuncao LDP, Lima PS, et al. Propionate metabolism in a human pathogenic fungus: proteomic and biochemical analyses. IMA Fungus. 2020;11:9. doi:10.1186/s43008-020-00029-9
   PubMed Web of Science ®Google Scholar
• Gomes AP, Ilter D, Low V, et al. Altered propionate metabolism contributes to tumour progression and aggressiveness. Nat Metab. 2022;4(4):435–443. doi:10.1038/s42255-022-00553-5
   PubMedGoogle Scholar
• Westerholm M, Calusinska M, Dolfing J. Syntrophic propionate-oxidizing bacteria in methanogenic systems. FEMS Microbiol Rev. 2022;46(2). doi:10.1093/femsre/fuab057
   PubMed Web of Science ®Google Scholar
• Mima K, Nishihara R, Qian ZR, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. 2016;65(12):1973–1980. doi:10.1136/gutjnl-2015-310101
   PubMed Web of Science ®Google Scholar
• Yoshida H, Ishii M, Akagawa M. Propionate suppresses hepatic gluconeogenesis via GPR43/AMPK signaling pathway. Arch Biochem Biophys. 2019;672:108057. doi:10.1016/j.abb.2019.07.022
   PubMed Web of Science ®Google Scholar
• Lu X, Qiao S, Peng C, et al. Bornlisy attenuates colitis-associated colorectal cancer via inhibiting GPR43-mediated glycolysis. Front Nutr. 2021;8:706382. doi:10.3389/fnut.2021.706382
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Wu T, Hu E, Xu S, et al. ClusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2(3):100141. doi:10.1016/j.xinn.2021.100141
   Web of Science ®Google Scholar
• Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York: Springer; 2000.
   Google Scholar
• Gordon M, Lumley T. Advanced forest plot using ‘grid’ graphics [R package forestplot version 1.10.1]; 2020.:
   Google Scholar
• Engebretsen S, Bohlin J. Statistical predictions with glmnet. Clin Epigenetics. 2019;11(1):123. doi:10.1186/s13148-019-0730-1
   PubMed Web of Science ®Google Scholar
• Tang S, Jing H, Huang Z, et al. Identification of key candidate genes in neuropathic pain by integrated bioinformatic analysis. J Cell Biochem. 2020;121(2):1635–1648. doi:10.1002/jcb.29398
   PubMed Web of Science ®Google Scholar
• Alboukadel Kassambara MK. Survminer: drawing survival curves using ‘ggplot2’. R package version 0.4.9. Available from: https://CRAN.R-project.org/package=survminer. Accessed September 29, 2023.
   Google Scholar
• Saha-Chaudhuri PJ. Survivalroc: time-dependent ROC curve estimation from censored survival data. R package version 1.0.3. Available from: https://CRAN.R-project.org/package=survivalROC. Accessed September 29, 2023.
   Google Scholar
• Liang L, Li J, Yu J, et al. Establishment and validation of a novel invasion-related gene signature for predicting the prognosis of ovarian cancer. Cancer Cell Int. 2022;22(1):118. doi:10.1186/s12935-022-02502-4
   PubMed Web of Science ®Google Scholar
• Kong W, Mao Z, Han C, et al. A novel epithelial-mesenchymal transition gene signature correlated with prognosis, and immune infiltration in hepatocellular carcinoma. Front Pharmacol. 2022;13:863750. doi:10.3389/fphar.2022.863750
   PubMed Web of Science ®Google Scholar
• Tao D, Wang Y, Zhang X, et al. Identification of angiogenesis-related prognostic biomarkers associated with immune cell infiltration in breast cancer. Front Cell Dev Biol. 2022;10:853324. doi:10.3389/fcell.2022.853324
   PubMed Web of Science ®Google Scholar
• Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7. doi:10.1186/1471-2105-14-7
   PubMed Web of Science ®Google Scholar
• Malta TM, Sokolov A, Gentles AJ, et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell. 2018;173(2):338–354 e15. doi:10.1016/j.cell.2018.03.034
   PubMed Web of Science ®Google Scholar
• Barriga V, Kuol N, Nurgali K, Apostolopoulos V. The complex interaction between the tumor micro-environment and immune checkpoints in breast cancer. Cancers. 2019;11(8):Aug. doi:10.3390/cancers11081205
   Web of Science ®Google Scholar
• Wang J, Kang Z, Liu Y, Li Z, Liu Y, Liu J. Identification of immune cell infiltration and diagnostic biomarkers in unstable atherosclerotic plaques by integrated bioinformatics analysis and machine learning. Front Immunol. 2022;13:956078. doi:10.3389/fimmu.2022.956078
   PubMed Web of Science ®Google Scholar
• Li S, Dong C, Chen J, Gao X, Xie X, Zhang X. Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma. Aging. 2021;13(12):16696–16712. doi:10.18632/aging.203189
   PubMedGoogle Scholar
• Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. Adv Cancer Res. 2021;149:1–61. doi:10.1016/bs.acr.2020.10.001
   PubMed Web of Science ®Google Scholar
• Sun J, Ding J, Shen Q, et al. Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes Hepatocellular carcinoma. J Hepatol. 2023;78(3):627–642. doi:10.1016/j.jhep.2022.11.017
   PubMed Web of Science ®Google Scholar
• Abdalkareem Jasim S, Jade Catalan Opulencia M, Alexis Ramirez-Coronel A, et al. The emerging role of microbiota-derived short-chain fatty acids in immunometabolism. Int Immunopharmacol. 2022;110:108983. doi:10.1016/j.intimp.2022.108983
   PubMed Web of Science ®Google Scholar
• Liu P, Wang Y, Yang G, et al. The role of short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis. Pharmacol Res. 2021;165:105420. doi:10.1016/j.phrs.2021.105420
   PubMed Web of Science ®Google Scholar
• Kang X, Bai L, Qi X, Wang J. Screening and identification of key genes between liver Hepatocellular carcinoma (LIHC) and cholangiocarcinoma (CHOL) by bioinformatic analysis. Medicine. 2020;99(50):e23563. doi:10.1097/MD.0000000000023563
   PubMed Web of Science ®Google Scholar
• Deng W, Zhu P, Xu H, Hou X, Chen W. Classification and prognostic characteristics of hepatocellular carcinoma based on glycolysis cholesterol synthesis axis. J Oncol. 2022;2022:2014625. doi:10.1155/2022/2014625
   PubMed Web of Science ®Google Scholar
• Lee YK, Lim JJ, Jeoun UW, et al. Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness. J Biol Chem. 2017;292(49):20208–20217. doi:10.1074/jbc.M117.809012
   PubMed Web of Science ®Google Scholar
• Wang X, Li Y, Shi Y, et al. Comprehensive analysis to identify the neurotransmitter receptor-related genes as prognostic and therapeutic biomarkers in Hepatocellular carcinoma. Front Cell Dev Biol. 2022;10:887076. doi:10.3389/fcell.2022.887076
   PubMed Web of Science ®Google Scholar
• Aeffner F, Zarella MD, Buchbinder N, et al. Introduction to digital image analysis in whole-slide imaging: a white paper from the digital pathology association. J Pathol Inform. 2019;10:9. doi:10.4103/jpi.jpi_82_18
   PubMedGoogle Scholar
• Hong L, Zhou Y, Xie X, et al. A stemness-based eleven-gene signature correlates with the clinical outcome of Hepatocellular carcinoma. BMC Cancer. 2021;21(1):716. doi:10.1186/s12885-021-08351-0
   PubMed Web of Science ®Google Scholar
• Chen J, Chen Z, Huang Z, Yu H, Li Y, Huang W. Formiminotransferase cyclodeaminase suppresses hepatocellular carcinoma by modulating cell apoptosis, DNA damage, and phosphatidylinositol 3-kinases (PI3K)/Akt signaling pathway. Med Sci Monit. 2019;25:4474–4484. doi:10.12659/MSM.916202
   PubMed Web of Science ®Google Scholar
• Cao F, Luo A, Yang C. G6PD inhibits ferroptosis in Hepatocellular carcinoma by targeting cytochrome P450 oxidoreductase. Cell Signal. 2021;87:110098. doi:10.1016/j.cellsig.2021.110098
   PubMed Web of Science ®Google Scholar
• Li Y, Li B, Xu Y, et al. GOT2 silencing promotes reprogramming of glutamine metabolism and sensitizes Hepatocellular carcinoma to glutaminase inhibitors. Cancer Res. 2022;82(18):3223–3235. doi:10.1158/0008-5472.CAN-22-0042
   PubMed Web of Science ®Google Scholar
• Bergers G, Fendt SM. The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021;21(3):162–180. doi:10.1038/s41568-020-00320-2
   PubMed Web of Science ®Google Scholar
• Xue R, Zhang Q, Cao Q, et al. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature. 2022;612(7938):141–147. doi:10.1038/s41586-022-05400-x
   PubMed Web of Science ®Google Scholar
• Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31–46. doi:10.1158/2159-8290.CD-21-1059
   PubMed Web of Science ®Google Scholar
• Li X, Ramadori P, Pfister D, Seehawer M, Zender L, Heikenwalder M. The immunological and metabolic landscape in primary and metastatic liver cancer. Nat Rev Cancer. 2021;21(9):541–557. doi:10.1038/s41568-021-00383-9
   PubMed Web of Science ®Google Scholar
• Zheng C, Zheng L, Yoo JK, et al. Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell. 2017;169(7):1342–1356 e16. doi:10.1016/j.cell.2017.05.035
   PubMed Web of Science ®Google Scholar
• Sun C, Xu J, Song J, et al. The predictive value of centre tumour CD8(+) T cells in patients with Hepatocellular carcinoma: comparison with immunoscore. Oncotarget. 2015;6(34):35602–35615. doi:10.18632/oncotarget.5801
   PubMedGoogle Scholar
• Yang Z, Deng Y, Cheng J, Wei S, Luo H, Liu L. Tumor-infiltrating PD-1(hi)CD8(+)-T-cell signature as an effective biomarker for immune checkpoint inhibitor therapy response across multiple cancers. Front Oncol. 2021;11:695006. doi:10.3389/fonc.2021.695006
   PubMed Web of Science ®Google Scholar
• Chen H, Li Z, Qiu L, et al. Personalized neoantigen vaccine combined with PD-1 blockade increases CD8(+) tissue-resident memory T-cell infiltration in preclinical Hepatocellular carcinoma models. J Immunother Cancer. 2022;10(9):Sep. doi:10.1136/jitc-2021-004389
   Web of Science ®Google Scholar